These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24392696)

  • 1. Emerging therapeutics for Alzheimer's disease.
    Chiang K; Koo EH
    Annu Rev Pharmacol Toxicol; 2014; 54():381-405. PubMed ID: 24392696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging amyloid and tau targeting treatments for Alzheimer's disease.
    Khan A; Corbett A; Ballard C
    Expert Rev Neurother; 2017 Jul; 17(7):697-711. PubMed ID: 28490214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to amyloid for Alzheimer's disease therapies-a symposium report.
    Cable J; Holtzman DM; Hyman BT; Tansey MG; Colonna M; Kellis M; Brinton RD; Albert M; Wellington CL; Sisodia SS; Tanzi RE
    Ann N Y Acad Sci; 2020 Sep; 1475(1):3-14. PubMed ID: 32472577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
    Mullane K; Williams M
    Biochem Pharmacol; 2020 Jul; 177():113945. PubMed ID: 32247851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer's disease or should they be looking elsewhere?
    Imbimbo BP; Ippati S; Watling M
    Expert Opin Drug Discov; 2020 Nov; 15(11):1241-1251. PubMed ID: 32686970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau therapeutics for Alzheimer's disease: the promise and the challenges.
    Gold M
    J Mol Neurosci; 2002 Dec; 19(3):331-4. PubMed ID: 12540060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging avenues for Alzheimer's disease drug targets.
    Loera-Valencia R; Cedazo-Minguez A; Kenigsberg PA; Page G; Duarte AI; Giusti P; Zusso M; Robert P; Frisoni GB; Cattaneo A; Zille M; Boltze J; Cartier N; Buee L; Johansson G; Winblad B
    J Intern Med; 2019 Oct; 286(4):398-437. PubMed ID: 31286586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment for Alzheimer's disease: current approaches and future strategies.
    Fan LY; Chiu MJ
    Acta Neurol Taiwan; 2010 Dec; 19(4):228-45. PubMed ID: 21213151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease.
    Ceyzériat K; Zilli T; Millet P; Frisoni GB; Garibotto V; Tournier BB
    Curr Alzheimer Res; 2020; 17(2):112-125. PubMed ID: 32129164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics.
    Hussain I
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):395-402. PubMed ID: 20522015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging treatments for Alzheimer's disease for non-amyloid and non-tau targets.
    Khan A; Corbett A; Ballard C
    Expert Rev Neurother; 2017 Jul; 17(7):683-695. PubMed ID: 28490260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
    Karran E; Mercken M; De Strooper B
    Nat Rev Drug Discov; 2011 Aug; 10(9):698-712. PubMed ID: 21852788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease.
    Herrup K; Carrillo MC; Schenk D; Cacace A; Desanti S; Fremeau R; Bhat R; Glicksman M; May P; Swerdlow R; Van Eldik LJ; Bain LJ; Budd S
    Alzheimers Dement; 2013 Jul; 9(4):452-458.e1. PubMed ID: 23809366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics.
    Mullane K; Williams M
    Biochem Pharmacol; 2018 Dec; 158():376-401. PubMed ID: 30273552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau-targeted treatment strategies in Alzheimer's disease.
    Götz J; Ittner A; Ittner LM
    Br J Pharmacol; 2012 Mar; 165(5):1246-59. PubMed ID: 22044248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging drug targets for Aβ and tau in Alzheimer's disease: a systematic review.
    West S; Bhugra P
    Br J Clin Pharmacol; 2015 Aug; 80(2):221-34. PubMed ID: 25753046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: Recent treatment strategies.
    Vaz M; Silvestre S
    Eur J Pharmacol; 2020 Nov; 887():173554. PubMed ID: 32941929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status and future directions of clinical trials in Alzheimer's disease.
    Plascencia-Villa G; Perry G
    Int Rev Neurobiol; 2020; 154():3-50. PubMed ID: 32739008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Y
    Matrone C; Iannuzzi F; Annunziato L
    Ageing Res Rev; 2019 Jul; 52():120-128. PubMed ID: 31039414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease.
    Morsy A; Trippier PC
    J Alzheimers Dis; 2019; 72(s1):S145-S176. PubMed ID: 31594236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.